Drug & supplement interaction

Chymotrypsin + Lorlatinib

Lorlatinib brand name: Lorbrena.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Chymotrypsin and Lorlatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Chymotrypsin and Lorlatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lorlatinib and Chymotrypsin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Chymotrypsin at all — not against Lorlatinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Chymotrypsin safety at a glance

Chymotrypsin overall Use caution Generally tolerated for short-term use, but quality evidence is limited and some people may react to this animal-derived enzyme.
Pregnancy Avoid There is not enough safety information, so it is best to avoid use during pregnancy.
Breastfeeding Avoid Safety while breastfeeding has not been established, so avoiding it is the safer choice.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lorlatinib and Chymotrypsin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

No Interaction Found — But Data Suggests Chymotrypsin and Lorlatinib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. One of them is worth acting on rather than waiting out — marked below.

  • Shortness of breath Worth acting on reported in 3.9% of FDA reports for Lorlatinib Additional detail

    Chymotrypsin

    “Rarely, chymotrypsin has been reported to cause anaphylactic reactions characterized by dyspnea, urticaria, edema, shock, vascular collapse, and unconsciousness, which can lead to death (9,509).”

    Chymotrypsin · Natural Medicines adverse-effect record, reported in pregnancy-related edema.

    2 sources cited
    1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
    2. 509. Dukes, MNG. Meyler's Side Effects of Drugs. 13th ed. Elsevier: Amsterdam, 1997.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • Swelling reported in 3.9% of FDA reports for Lorlatinib Additional detail

    Chymotrypsin

    “Intraocular injections of chymotrypsin have been reported to cause increased intraocular pressure, corneal edema, striation, uveitis, iridoplegia, and filamentary keratitis (9,509).”

    Chymotrypsin · Natural Medicines adverse-effect record, reported in uveitis.

    2 sources cited
    1. 9. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
    2. 509. Dukes, MNG. Meyler's Side Effects of Drugs. 13th ed. Elsevier: Amsterdam, 1997.

    Lorlatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lorlatinib, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

Reported for Chymotrypsin but not commonly for Lorlatinib: an allergic reaction, a severe allergic reaction and hives.

Effects for Lorlatinib come from the ADVERSE REACTIONS section of its FDA label; effects for Chymotrypsin come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 6,977 voluntary FDA FAERS reports for Lorlatinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Everything else you take

See Every Supplement That Interacts With Lorlatinib

This page covers Chymotrypsin only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lorlatinib page lists 153 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate) and Adrafinil (moderate).

By severity: 3 major · 110 moderate · 40 minor.

From our pharmacist’s overview on the Lorlatinib page

“Lorlatinib (Lorbrena) treats ALK-positive lung cancer, and keeping its blood level steady is central to keeping the cancer controlled, so I treat this list with genuine vigilance. Nearly all 153 interactions on file run through CYP3A4, the enzyme that clears the drug.”

Reviewed by 2 · Jul 18, 2026

Open the Lorlatinib interaction page

One more smart check

Taking Chymotrypsin as Part of a Dietary Supplement Product? Check It for Interactions

We hold 281 real supplement products containing Chymotrypsin, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Chymotrypsin. Even though Chymotrypsin itself has no known interaction with Lorlatinib, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Chymotrypsin and Lorlatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Chymotrypsin
Top half

#577 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lorlatinib
Steady interest

#2,010 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Chymotrypsin reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Chymotrypsin and Lorlatinib records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Chymotrypsin

What is Chymotrypsin?

  • Swelling and inflammation after injury or surgery
  • Wound healing
  • Cataract surgery (intracapsular)
  • Sports injuries and sprains
  • Easing soreness and bruising

Chymotrypsin is a protein-digesting (proteolytic) enzyme, usually taken from the pancreas of cattle or pigs, that is mainly used to help reduce swelling and support healing after injury or surgery. The evidence for many of these uses is limited or low quality, so it should not replace standard care. Talk with your pharmacist or doctor before using it, especially if you are pregnant, breastfeeding, or have a bleeding or clotting condition.

Enzyme derived from animal (typically bovine or porcine) pancreas · Oral tablets (often enteric-coated), topical preparations, injectable forms (in clinical settings)

An interaction check asks whether these two react with each other — it does not ask whether Chymotrypsin is a good idea for someone in your situation. Here is what our Chymotrypsin record says about it on its own.

Chymotrypsin: dosing

There is no well-established standard dose of chymotrypsin for supplement use. Strengths vary widely between products, and it is often combined with other enzymes such as trypsin.The best approach is to follow the directions on the product label and not exceed the recommended amount.

From our Chymotrypsin monograph — the full record covers uses, side effects and every documented interaction.

Read the full Chymotrypsin monograph & all interactions
Medication

About Lorlatinib

What Is Lorlatinib Used For?

Brand name: Lorbrena

Lorbrena (lorlatinib) is used to treat adults with metastatic non-small cell lung cancer (NSCLC) — meaning lung cancer that has spread — when lab testing confirms the tumor is ALK-positive (has a specific gene change that drives cancer growth). Patients must be tested with an FDA-approved diagnostic test before starting treatment.

Lorbrena has been studied in patients who have not yet received treatment for advanced disease, as well as in patients whose cancer progressed on other ALK-targeting medicines.

Most-Reported Side Effects for Lorlatinib

From FAERS, the FDA’s public side-effect reporting system (6,977 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Neoplasm progression 621 reports
Hallucination 404 reports
Weight increased 399 reports
Blood cholesterol increased 348 reports
Dyspnea 270 reports
See full Lorlatinib drug information
Keep checking

Other Drugs & Chymotrypsin

Browse every other medication we’ve checked against Chymotrypsin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Chymotrypsin References

The 6 references that drive our Chymotrypsin monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
  2. Dukes, MNG. Meyler's Side Effects of Drugs. 13th ed. Elsevier: Amsterdam, 1997.
  3. Latha B, Ramakrishnan M, Jayaraman V, Babu M. Serum enzymatic changes modulated using trypsin: chymotrypsin preparation during burn wounds in humans. Burns 1997;23:560-4. PubMed
  4. Shaw PC. The use of a trypsin-chymotrypsin formulation in fractures of the hand. Br J Clin Pract 1969;23:25-6. DOI
  5. McCue FC, Webster TM, Gieck J. Clinical effects of proteolytic enzymes after reconstructive hand surgery. Int Surg 1972;57:479-82.
  6. Sun HJ, Xiao JQ, Qiao QH, et al. Chymotrypsin with sialendoscopy-assisted surgery for the treatment of chronic obstructive parotitis. Int J Oral Maxillofac Surg 2017;46(7):877-82. doi: 10.1016/j.ijom.2017.02.1267. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Chymotrypsin and Lorlatinib Together: Common Questions

Is it safe to take Chymotrypsin with Lorlatinib?
We do not list a known interaction between Chymotrypsin and Lorlatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Chymotrypsin and Lorlatinib have any of the same side effects?
Yes — our sources link each of them separately to 2 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Does Lorlatinib interact with any supplements?
Yes. Lorlatinib has documented interactions with 153 supplements in our database — Chymotrypsin is not one of them. The Lorlatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Lorlatinib and Chymotrypsin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.